iPath for CP Pilot
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center
About this trial
Depression is a significant problem in care partners of people living with dementia; despite the expansion of options for accessing evidence-based treatments, most care partners of people living with dementia are not screened for depression and do not receive treatment. The objective of this project is to identify a screening method for depression that is feasible and acceptable to care partners and to adapt an innovative pathway to online evidence-based treatment for depression (iPath\*D) as a means of increasing mental health literacy, screening rates and treatment access for care partners of people living with dementia. The results are expected to have a major positive impact by providing proof-of-principle for the use of an online pathway to evidence based treatment with the potential for reaching an unprecedented number of care partners who have unmet mental health needs.
Eligibility criteria
Qualifiers
Adults (≥18 years)
Care partners of persons with dementia who score ≥5 on the PHQ-8 AND PHQ-9 screen
Can communicate in English
Have access to an Android based or Apple iOS based phone or tablet capable of running the iPath application.
Disqualifiers
PHQ-8 score <5
Answering positively for question 9 of the PHQ-9 who also screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6b ("Past 3 Months") on the Columbia-Suicide Severity Rating Scale (C-SSRS) and determined by Dr. Mistler, Psychiatrist at DH, not to be eligible.
With bipolar disorder or psychosis (documented in the electronic medical record [EMR])
With significant cognitive impairment (documented in the EMR or self-reported during eligibility screening)
Trial design
Treatments tested in this trial
- depression app for care partners of persons with dementia
Treatment groups
15 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov